Thales-Exail: Agreement Finalized, Mandatory Bid at 134 € and Acquisition of Gorgé Family's 35.51% Stake
On July 30, 2026, Thales and Exail Technologies finalized their merger agreement, defined the terms of Thales's acquisition of the Gorgé family's stake (35.51% of capital) and clarified the timetable for the mandatory public offer at 134 € per share.
Agreement Signed Concerning the Acquisition of the Gorgé Stake
Thales and Exail Technologies have signed the merger agreement, the opening of negotiations for which was announced on July 6, 2026. This document sets out the terms of Thales's acquisition of all shares and ODIRNANE issued by Exail Technologies and not held by the Gorgé family, in the context of a mandatory public offer. The proposed price remains fixed at 134.00 € per share, in accordance with the initial announcement.
Implementation Timetable and Appointment of the Independent Expert
The completion of the acquisition of the Gorgé family's stake, representing 35.51% of Exail Technologies' capital, is expected by the third quarter of 2027, subject to obtaining customary regulatory authorizations, particularly in matters of competition. The public offer for purchase covering 100% of the shares and ODIRNANE will subsequently be filed with the Financial Markets Authority, with completion expected by early 2028.
The board of directors of Exail Technologies has appointed the firm Ledouble, represented by Olivier Cretté and Romain Delafont, as independent expert. The board of directors, which welcomes this operation, will issue a reasoned opinion after examining the expert's fairness opinion.